GLP-1 Hair Loss: What the Labels Say and What Helps

GLP-1 hair loss is a real but uncommon side effect. Both the Wegovy® (semaglutide) and Zepbound® (tirzepatide) labels list hair loss, reported more often than with placebo and linked to weight reduction. The usual pattern is temporary, diffuse shedding called telogen effluvium, which often improves with time and good nutrition. Talk with your provider before changing anything.

This guide covers what the FDA labels report, why losing weight can trigger shedding, what may help, and when to reach out.

Key takeaways

• Hair loss appears in both the Wegovy® and Zepbound® labels, and both say it was associated with weight reduction.
• In the trials it was more common in women than in men.
• The most common pattern after weight loss is telogen effluvium: diffuse shedding that tends to start a few months after the trigger and usually resolves.
• Good nutrition and ruling out other causes are the main things you and your provider can work on.
• Do not stop your medication on your own. Your provider decides whether anything changes.

What the labels report about hair loss

The table below uses figures from the FDA-approved prescribing information. They describe groups in clinical trials, not what will happen to you.

A few more details from the labels:

• Higher Wegovy® dose. In trials of the higher Wegovy® injection dose, hair loss was reported in 5.8% of patients, versus 1.0% on placebo, again mostly in women.
• Pediatric trial. In a pediatric Wegovy® trial, hair loss was reported in 4% of patients on the medication and in none on placebo.
• Stopping treatment. In the pooled Zepbound® weight trials, no patient on the medication stopped because of hair loss.

For the full list of side effects of each medication, see our guides to semaglutide side effects and whether tirzepatide is safe.

Why weight loss can cause shedding: telogen effluvium

Hair grows in cycles. Most scalp hairs are in a growth phase at any given time, and telogen is the resting phase before a hair sheds. In telogen effluvium, a stress on the body pushes many growing hairs into the resting phase early, so more hairs than usual shed at around the same time, a few months later.

A 2021 review in the Journal of Dermatological Science describes telogen effluvium as a common cause of diffuse, non-scarring hair loss, usually set off by physiological stress such as childbirth or sudden weight loss, with a high rate of remission. Another review notes that diffuse shedding is seen about 3 to 4 months after the triggering event. That delay is why shedding can seem to come out of nowhere, long after you started treatment.

Rapid weight loss is a known trigger whatever the cause. A 2024 study of 140 people with telogen effluvium after weight loss found that women and older adults were especially vulnerable, even when their weight loss was not greater than that of men or younger adults.

What about GLP-1 medications specifically? A 2026 meta-analysis pooling observational data found a higher risk of non-scarring hair loss among people using GLP-1 medications, driven mainly by telogen effluvium and pattern hair loss. The authors concluded the link is mainly explained by nutrient shortfalls that come with weight loss. Observational studies cannot prove cause, so that remains the authors' interpretation, not a settled fact.

What may help

There is no guaranteed way to prevent shedding, but these steps address the usual contributors:

• Eat enough protein and a varied diet. When portions shrink, it is easier to fall short on protein and other nutrients. Our guide to protein on GLP-1 includes a calculator you can use to estimate your needs.
• Do not skip meals entirely. Smaller, regular meals built around protein, vegetables, fruit and whole grains help cover nutrients when portions are small. See what to eat on a GLP-1 for meal ideas.
• Ask about lab work. One review of telogen effluvium recommends history and lab tests to rule out endocrine, nutritional and autoimmune causes. Your provider may check thyroid function, iron stores or other labs.
• Give it time. In the 2024 study of weight-loss shedding, every patient improved during follow-up, but recovery took months. The acute form of telogen effluvium usually resolves with hair regrowth.

Ask your provider before adding supplements marketed for hair, so they can check whether you actually need them.

When to call your provider

Message your provider if you notice more hair than usual in your brush or shower drain. It is not an emergency, but it is worth mentioning early, and your provider can review your nutrition and your plan. Do not stop or change your medication on your own.

Ask for a prompt evaluation if you see:

• Patchy bald spots rather than diffuse, all-over thinning.
• Scalp redness, scaling, pain or scarring.
• Hair loss together with other new or unexplained symptoms.
• Shedding that keeps going for many months.

Telogen effluvium is diffuse and does not scar, so these patterns may point to a different cause that needs its own care, sometimes with a dermatologist.

Call 911 for any medical emergency. Hair loss on its own is not one, but severe symptoms such as trouble breathing, swelling of the face or throat, or severe abdominal pain always need urgent care.

Talk with a licensed provider

If you are weighing a GLP-1 medication and hair loss is on your mind, bring it up in your visit. A licensed provider can review your health history, explain the side effects of each option and help you plan nutrition from day one. Read the Important Safety Information for semaglutide and tirzepatide, explore the semaglutide program, and start your health assessment when you are ready. Online visits are available in . Submitting an assessment does not guarantee a prescription; a licensed provider decides.

Brand names are trademarks of their respective owners. Forever Health Rx is not affiliated with Novo Nordisk or Eli Lilly.